BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+8.55%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.28B
AUM Growth
+$1.28B
(-1.8%)
Cap. Flow
-$17.3M
Cap. Flow
% of AUM
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
1
Closed
–
Top Buys
| 1 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$3.13M |
| 2 |
STAAR Surgical
STAA
|
$1.95M |
Top Sells
| 1 |
Axon Enterprise
AXON
|
$22.4M |
Sector Composition
| 1 | Consumer Staples | 34.06% |
| 2 | Industrials | 33.54% |
| 3 | Healthcare | 23.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monster Beverage
MNST
$60.9B
| $436M | 34.06% | 8,295,690 | – | – |
|
|
2
Axon Enterprise
AXON
$58.7B
| $429M | 33.54% | 722,421 -37,641 | -5% | -$22.4M |
|
|
3
STAAR Surgical
STAA
$1.36B
| $264M | 20.59% | 10,848,631 +80,200 | +0.7% | +$1.95M |
|
4
iShares Russell 2000 ETF
IWM
$67B
| $115M | 8.98% | 519,920 | – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $20.9M | 1.64% | 41,666,255 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $14.9M | 1.16% | 6,244,405 +1,315,339 | +27% | +$3.13M |
|
7
Serina Therapeutics
SER
$54.5M
| $427K | 0.03% | 85,219 | – | – |
|